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Several neurological disorders have been linked to inﬂammatory insults suﬀered during development. We investigated the eﬀects
of neonatal systemic inﬂammation, induced by LPS injections, on blood-brain barrier permeability, endothelial tight junctions
and behaviour of juvenile (P20) and adult rats. LPS-treatment resulted in altered cellular localisation of claudin-5 and changes
in ultrastructural morphology of a few cerebral blood vessels. Barrier permeability to sucrose was signiﬁcantly increased in LPS
treated animals when adult but not at P20 or earlier. Behavioural tests showed that LPS treated animals at P20 exhibited altered
behaviour using prepulse inhibition (PPI) analysis, whereas adults demonstrated altered behaviour in the dark/light test. These
data indicate that an inﬂammatory insult during brain development can change blood-brain barrier permeability and behaviour
inlater life.Italsosuggeststhatthe impactofinﬂammationcanoccur inseveralphases(short-andlong-term) andthateach phase
might lead to diﬀerent behavioural modiﬁcations.
1.Introduction
Human data related to disorders such as autism, schizophre-
nia, and cerebral palsy indicate that a period of infection/
inﬂammation during speciﬁc stages of brain development
may act as a triggering insult [1–4]. In animal experimental
studies, inﬂammation induced during the early postnatal
period in rodents has been associated with increased blood-
brain barrier permeability [5], white matter damage [6–13],
ventricular enlargement [9, 14], and reduced neuron num-
bers in regions of the hippocampus and cerebellum [15, 16].
In addition, in animals exposed to inﬂammation in utero or
during early postnatal life, long-term behavioural alterations
such as deﬁcits in prepulse inhibition test [17, 18], motor
behaviour [19], and learning and memory [19, 20]h a v ea l s o
been reported. However, the biologicalmechanisms involved
inthesepathologiesarestillnotunderstood.Todatethereare
no studies that directly investigated possible links between
changes in blood-brain barrier permeability and behavioural
alterations in animals exposed to an inﬂammatory mediator
during early stages of brain development.
In this study, we have investigated possible correlations
between some behavioural tests and blood-brain barrier
morphology and permeability in adolescent and adult rats
that were exposed to a prolonged inﬂammatory stimulus
(LPS-injections) as neonates. To examine possible cellular
mechanisms behind the alteration in blood-brain barrier
permeability, the distribution of claudin-5, a key tight junc-
tionproteinshown todirectlyaﬀectbarrierpermeability[21,
22], was visualised by immunocytochemistry and electron
microscopy was used to study the ultrastructure of brain
blood vessels in these animals.
2.Materialsand Methods
2.1. Animal Model. All experiments were approved by the
University of Melbourne Animal Ethics Committee accord-
ing to NH&MRC guidelines. Sprague-Dawley rats were2 Cardiovascular Psychiatry and Neurology
sourced from the Breeding Research Facility at University of
Melbourneandallanimalswerekeptundersimilarcondition
in standard animal cageswith sawdust bedding,free accessto
food (Specialty feed rat pellets)/water, and under controlled
environment (12h day/light cycle, 20-21◦C and 50–60%
relative humidity). During the light period, the illumination
in the room was >350 lux (1 meter above ground) and
background noise due to air-conditioning was about 55dB.
Newborn rats were given ﬁve 0.2mg/kg intraperitoneal
(i.p.)injections oflipopolysaccharide (LPS, E. coli055:B5)or
equal volume of sterile saline (control animals) at postnatal
day 0 (P0), 2, 4, 6, and 8, to produce a prolonged period
of inﬂammation over the postnatal period [11]. Litters were
marked and equally divided into saline- and LPS-treated
cohorts, including both male and female animals. During
the period of treatment (P0–P8), LPS-injected animals
had a signiﬁcantly lower body weight compared to saline-
injected controls. At P8 LPS-treated pups weighed 18.1 ±
0.6gcomparedto22.8 ± 0.7g for controls (mean ± SEM;
n = 29 for each group). The body weight was still lower
at P20 in LPS-injected animals (controls 65 ± 2g, 56 ±
2g for LPS-treated animals; ∗∗∗P = .0003, n = 20 for
each group), whereas no signiﬁcant diﬀerence was found in
adults (controls 224 ± 14g, LPS-treated animals 239 ± 16g;
P = .51, n = 11 for each group).
Animals were left until either P20 or adulthood for
behavioural testing; blood-brain barrier permeability mea-
surements were made at P9 and P20 (we have previously
published adult sucrose permeability data [11]), claudin-5
immunocytochemistry was performed at P9, P20 and adult;
ultrastructural examination of cerebral blood vessels was
carried out on adult material only.
2.2. Behavioural Tests. All behavioural tests were performed
at the Integrative Neuroscience Facility, Howard Florey
Institute. Animals were acclimatised to the facility for a week
before testing and 1-2 day recovery periods were allowed
betweeneachsetoftests.Theﬁrsttwotestswereconductedat
P20 (n = 35, 2 days following weaning) and in adult animals
(n = 16),whereas thelast two tests(Open ﬁeld, Morris water
maze) were carried out in adults only, as P20 animals were
too young to cooperate. Diﬀerent cohorts of animals were
tested at P20 and as adults to avoid inﬂuences in adult
responses due to previous exposure to behavioural testing
conditions. Rats were tested in random order and under
similar environmental conditions to those under which they
were normally kept unless speciﬁcally stated below.
2.2.1. Prepulse Inhibition and Acoustic Startle Response. For
thistestthe animal was placedin a 9cmdiameter cylinderon
a movement-sensitive platform inside a sound-attenuating
boxwithabackgroundsoundlevelof70dB.Over40minutes
a programme of randomly ordered sound stimuli, with
25 second intervals, was given. These included the 115dB,
40msec startle stimuli either by itself or preceded by a
100msec weak prepulse nonstartling stimulus at 74, 78, or
86dB (i.e.,4,8 and 16dBabove background),and no stimuli
periods. The same programme of sound stimuli was used
for each animal. The startle response (a jumping reﬂex that
lasts for less than one second) was measured by STARTLE
software.
2.2.2. Light/Dark Test. Animals were placed in a 40 × 40cm
arena, divided into a light (750 lux) and dark (no light) half
by a Perspex insert, with a Tru scan locomotor system (light
sensors measuring movement in the vertical and horizontal
planes) and Tru scan software for live data recording and
analysis. After 10 minutes the session was stopped and the
animal was returned to itscage.The movement ofthe animal
was analysed including the latency of the ﬁrst entry and
number of entries into the light half.
2.2.3. Open Field Exploration Test. The general locomotor
activity of the adult animals was determined in open ﬁeld
exploration. Animals were placed in a 40×40cmarena setup
with a Tru scan locomotor system and Tru scan software
for live data recording and analysis. After 1 hour the session
was stopped and the animal returned to its cage. Analysis of
movement, detected by the Tru Scan locomotor system, was
c o n d u c t e df o rh o r i z o n t a la n dv e r t i c a lp l a n e sa sw e l la st h e
movement of the animal along the margins or the centre of
the arena.
2.2.4. Morris Water Maze. A circular water maze pool (2m
diameter) was ﬁlled to a depth of 30cm with 25◦Cw a t e r
and enough nontoxic paint to make the water opaque. A
circular 15cm diameterplatform was submerged 1cmbelow
the water level in one quadrant of the pool. The animal was
placed in the water in a random quadrant and allowed 2
minutes to ﬁnd the platform. The time to ﬁnd the platform
was recorded. The animal was left for 30 seconds on the
platform before being removed, dried and placed under
a warming lamp before repeating the test with the same
platform location, but the animal entering the pool in a
diﬀerent quadrant. The testing procedure was repeated daily
until the animals showed no improvement in the time taken
to ﬁnd the platform. For a ﬁnal test, the platform was
removed and the animal was introduced to the pool for 1
minute. The frequency and duration the animal spent in the
platform zone (the zone where the platform used to be) were
measured.
2.3. Blood-Brain Barrier Permeability. Brain/plasma sucrose
concentration ratios were measured as an index of blood-
brain barrier permeability in animals that had been injected
with either LPS or saline as neonates (see above). Due to
the small size of P9 animals, diﬀerent methods were used
to estimate concentration ratios at younger (P9) and older
(P20) ages (n = 6 for each age group and treatment).
InP9animals,serialbloodsamplingisnotpossiblethere-
fore, in order to obtain proper steady state concentration
ratios, nephrectomy was performed under isoﬂurane (3%)
anaesthesia before an i.p. injection (6μL/g body weight) of
1μCi 14C-sucrose (Amersham, CFB146). Animals regained
consciousness and were kept under a heat-lamp at 28◦C.
Three hours after the sucrose injection, when concentrationCardiovascular Psychiatry and Neurology 3
ratios achieve a near to steady state level [23], the animals
were terminally anaesthetised with halothane and blood and
brainscollected.Plasma wasseparatedbycentrifugation.The
brain was divided into cerebral hemispheres, midbrain, cere-
bellum and brainstem and frozen before further processing.
In P20 rats serial blood sampling was possible, and was
used to construct the plasma radioactivity curve following
radiolabel injection [11]. In anaesthetised animals, the left
femoral vein and artery were cannulated, and 2μCi (P20)
of 14C-sucrose was injected (6μL/g body weight) via the
venous cannula, followed by an equal volume of saline.
Blood was collected (60–80μL) from the arterial cannula
into heparinised glass capillaries every 5 minutes until the
end of the experiment (30 minutes) and plasma separated
by centrifugation. Immediately after the last blood sample
was collected the heart was transected to prevent further
circulation of the tracer and the brain dissected out. The
brain was divided into the cerebral hemispheres, midbrain,
cerebellum and brainstem and frozen.
Soluene-350 (0.5mL, Packard Biosciences) was added to
each vial with brain tissue and left for 48 hours at 37◦C
to completely solubilise the tissue. Following this, 4.5mL
of scintillation ﬂuid (Ultra Gold, Packard Biosciences)
was added to all vials with brain or plasma samples.
The radioactivity in each vial was determined by liquid
scintillation counting (1409 DSA, Wallac) and expressed as
dpm/μg sample. Brain/plasma sucrose concentration ratios
were calculated as has been described before [11]. We have
previously measured permeability in adult animals using the
same treatment protocol and methods as for P20 animals
[11], and data are presented along with the results from this
study.
2.4. Claudin-5 Immunocytochemistry. LPS or saline-injected
animals at P9, P20 and adult were terminally anaesthetised
with inhaled isoﬂurane (P9) or i.p. Nembutal (P20 and
adults; 0.1-0.2mL/100g, Rhone Merieux) before perfusion
throughtheaortawithheparinised phosphatebuﬀeredsaline
(PBS, pH 7.4) followed by 4% paraformaldehyde in 0.1M
phosphate buﬀer (pH 7.4). Brains were removed from the
skull, postﬁxed in Bouin’s ﬁxative for 24 hours and processed
and sectioned for histology. Brieﬂy, tissue was dehydrated
through increasing concentrations of ethanol, cleared in
chloroform and embedded in paraﬃn wax. Sections were
cut coronally with a thickness of 5μm on a Bright rotary
microtome (Leica) [5, 11].
Claudin-5 protein was detected in paraﬃn embedded
tissue sections using the PAP method of immunohistochem-
istry. Sections were dewaxed, rehydrated and incubated in
Peroxidase Blockerfollowed by Protein Blocker(1 houreach;
Blockers sourced from DAKO). Sections were exposed to
the primary antibody, mouse anticlaudin-5 (Zymed, diluted
1:200) overnight at 4◦C. Secondary rabbit antimouse anti-
body and mouse-PAP (DAKO)were used following standard
procedures [11] and sections developed for approximately
5 minutes using the DAB+ kit (DAKO). Between each
incubation step, sections were washed 3 × 5m i n u t e sw i t h
PBS-Tween20 (pH 7.4). Controls included incubating slides
with one of the antibodies omitted and were always blank.
Immunocytochemical distribution of claudin-5 in
microvessels was determined under light microscope to be
either “junctional” or “cytoplasmic” as described previously
[11]. The proportion of vessels with either appearance in
the cortex and white matter (corpus callosum and external
capsule) was determined and scored by the same blinded
observer (KMD, 3–6 sections were counted per brain, n = 3
brains in each group).
2.5. Electron Microscopy. For morphological examination
of blood vessels with an electron microscope tissue was
collected from adult rats exposed to either LPS or saline as
neonates (n = 3-4 for each group). Animals were anaes-
thetised as described above and perfused transcardially with
50mL heparinised phosphate buﬀered saline followed by
200mL solution of 2% paraformaldehyde/2.5% glutaralde-
hyde in phosphate buﬀer (0.1M, pH 7.3). Several tissue
blocks (up to 1mm3a piece) were cut from diﬀerent parts of
the corpus callosum and external capsule from each animal
and postﬁxed overnight in the same ﬁxative. Tissue was
washed in sodium cacodylate buﬀer (0.1M, pH 7.3, 3 × 20
minutes) before processing with a 2% osmium tetroxide/1%
potassium ferricyanide solution followed by uranyl acetate
treatment. Tissue was dehydrated in increasing concentra-
tions of acetone and embedded in Araldite Epon. Ultrathin
sections were cut with a Reichard UltraE microtome and
contrasted with uranyl acetate and lead citrate. Thirty to
ﬁfty blood vessels from each tissue block were examined
under a Phillips CM10 electron microscope to determine
theirultrastructurewithspecialfocusontheintegrityoftight
junctions.
2.6. Statistical Analysis. Comparisons between saline-(con-
trol) and LPS-(experimental) injected animals were made
using regression analysis for the prepulse inhibition test. For
all other data, diﬀerences between control and experimental
animal groups were compared for statistical signiﬁcance
using Student’st-tests with corrections for multiple compar-
isons. A P-value oflessthan .05 wasconsidered signiﬁcant in
all cases.
3.Results
3.1. Behavioural Tests. The eﬀect of systemic inﬂammation
during early postnatal development of the rat on behaviour
inlaterlifewasdeterminedusingbehaviouraltestspreviously
shown to be associated with early life exposure to inﬂamma-
tion, such as anxiety (light/dark test) and altered prepulse
inhibition (PPI) as well as general tests of motor behaviour
and learning.
3.1.1. Prepulse Inhibition and Acoustic Startle Response.
Acoustic startle response and prepulse inhibition were
measured as part of one test. No signiﬁcant diﬀerence in
acoustic startle response was observed between LPS-treated
or control animals at either P20 or adult (data not shown).
However, a signiﬁcant decrease in prepulse startle inhibition
wasobservedinLPS-treatedanimalsatP20(linearregression4 Cardiovascular Psychiatry and Neurology
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Figure 1: The sensory motor gaiting of animal cohorts was tested
using the prepulse inhibition paradigm. Animals were exposed to
a 115dB stimulus either alone or with a 4, 8 or 16dB prepulse.
The presence of a prepulse inhibits the startle response produced
by the 115dB stimulus alone. Data are presented as percent
startle inhibition (mean ± SEM) for each prepulse intensity. At
P20 (a), animals exposed to LPS had reduced startle inhibition
compared to saline-injected age-matched controls (∗∗P<. 01,
linear regression analyses; n = 29). Adult animals (b) showed no
signiﬁcantdiﬀerence between groups ofanimalsalthoughthere was
a trend toward reduced startle inhibition at 16dB prepulse in LPS-
treated animals (n = 8 for each data point).
analysis, ∗∗P<. 01,Figure 1(a)).Inadultanimals therewasa
trend towards a decreased prepulse inhibition at the higher
prepulse intensity (16dB), the diﬀerence was not statistically
signiﬁcant (Figure 1(b)).
3.1.2. Light/Dark Test. P20 LPS-treated animals showed a
small but signiﬁcant decrease in their total moves in the
Light/Dark test (∗P = .02, Figure 2(a))c o m p a r e dt ot h o s e
Table 1: Brain/plasma sucrose concentration ratios.
Age Control LPS
P9 12.5 ± 0.6( n = 6) 11.9 ± 1.6( n = 6)
P20 2.6 ± 0.2( n = 6) 2.1 ± 0.1( n = 6)
Adult 2.3 ±0.4
∧ (n = 7) 4.2 ±0.5∗∧ (n = 7)
Note: P9 ratios were from nephrectomised awake animals 3 hours after
an i.p. injection, whereas ratios in older animals were 30min ratios in
anaesthetisedanimalsafteran i.v.injection.Dataare mean ± SEM, ∗P<. 05
from control, ∧data published previously [11].
treated with saline. However, no changes in their entrance
into thelight half of the apparatus, the time spent inthe light
halforthelatencytoenterthelighthalfwasdetected(Figures
2(b) and 2(c)). In contrast, in adult animals LPS treatment
resulted in signiﬁcantly increased entries into the light half
of the apparatus as well as earlier entry and more time spent
in the light half of the chamber (Figures 2(b) and 2(c)).
They also showed generally more exploratory behaviour, as
indicated by increased vertical plane entries (Figure 2(b)).
3.1.3. Open Field Exploration Test. LPS-treated adult rats
showed no diﬀerence from control animals in any of the
parameters analysed such as the total number of moves
(884 ± 62 versus 895 ± 60), time (sec) moving (1321 ± 127
versus 1383 ± 136), or in their velocity (cm/sec, 1522 ± 209
versus 1508 ± 223).
3.1.4. Morris Water Maze. Adult animals exposed to LPS
during their early postnatal development showed no sig-
niﬁcant diﬀerences in behaviour from the saline-injected
controls in the Morris Water Maze, with no changes in the
time taken to learn the location of a submerged platform or
their exploratory behaviour when the platform was removed
(Figures 3(a) and 3(b)).
3.2. Blood-Brain Barrier Permeability. Results from per-
meability studies performed in this paper are only valid
within each age group and cannot be directly compared
between P9 and older animals since diﬀerent methods were
used at diﬀerent ages to determine brain/plasma sucrose
concentration ratios (see Methods). Results are presented in
Table 1.A tP 9a n dP 2 0t h e r ew a sn os i g n i ﬁ c a n td i ﬀerence
in permeability of the blood-brain barrier between the LPS
and saline-treated groups of animals. At P9 the brain/plasma
sucrose concentration ratios of control animals were 12.5 ±
0.6% (mean ± SEM) compared to 11.9 ± 1.6% in LPS-
treated animals (P = .8). At P20 the brain/plasma sucrose
concentration ratios in controls were 2.6 ± 0.2% compared
to 2.1 ± 0.1% (P = .1) in LPS-treated animals (see Table 1).
In contrast, in adult animals we have shown previously [11]
there is a signiﬁcant increase in the brain/plasma sucrose
concentration ratios following early postnatal LPS treatment
(4.2 ± 0.5% in LPS-treated animals compared to 2.5 ± 0.4%
for controls, ∗P<. 05).
3.3. Claudin-5 Immunocytochemistry. Claudin-5 is so far the
only tight junction protein that has been experimentallyCardiovascular Psychiatry and Neurology 5
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Figure 2: The behaviour of P20 and adult animals in a stressful
environment was determined in an arena where half was brightly
lit and the other half was dark and enclosed. Total moves (a) and
entriesintothelighthalfandtheverticalplaneweredetermined(b),
as well as time spent in the light half and latency (c). P20 animals
exposed to LPS during postnatal development showed a small
but signiﬁcant decrease in total movement in this apparatus, but
otherwise showed no changes compared to saline-injected controls
(n = 8 for each group). Adult animals treated with LPS showed
increased exploratory behaviour with increased time and entries
into the light half of the arena, reduced latency to enter the light
half and increased vertical plane entries (∗P<. 05, data are mean ±
SEM, n = 8 for each group).
shown to directly aﬀect the permeability of the blood-brain
barrier [22], therefore its distribution was investigated using
immunocytochemistry on paraﬃn-embedded brain sections
(see Methods) and the results are illustrated and summarised
inFigure 4.Insaline-injectedcontrolanimalsatallagesstud-
ied (P9, P20 and adult), claudin-5 immunohistochemistry
showed a typical cell-to-cell junction distribution pattern
(Figures 4(a) and 4(c)) in approximately 80–100% of vessels
(indicated as ++++ in Figure 4(e)) within the cortex and
white matter while in the remaining cerebral blood vessels
distribution of the claudin-5 immunoreactivity appeared
more cytoplasmic. Distribution of claudin-5 immunore-
activity in brains from all LPS-treated animals showed a
distinct shift, typically exhibiting less junctional staining and
a relatively more cytoplasmic distribution (see Figures 4(b),
4(d),a n d4(e)).
3.4. Ultrastructure of Cerebral Blood Vessels. The ultrastruc-
ture of blood vessels, and speciﬁcally tight junctions, in
the white matter (external capsule and corpus callosum)
was examined. Tissue was compared from adult control
animals and adult animals that had been exposed to LPS
during development. All vessels examined from control
brains appeared to have a normal ultrastructure, with
little perivascular space, close association of astrocytic end
feet, well deﬁned basement membrane (Figure 5(a))a n d
obvious tight junctions between the intercellular clefts of
apposing endothelial cells (Figure 5(c)). Most vessels in
white matter from LPS-treated animals were not obviously
diﬀerent from control brains (Figure 5(b)). Tight junctions
were apparent at cell-cell contacts (Figure 5(d)), as were the
associations with the surrounding structures. However, in 2
out of 50 vessels in sections from the LPS-treated animals,
ultrastructural abnormalities were observed (Figure 5(e)). In
these vessels the lumen was convoluted and there was an
apparent disruption of the perivascular space. Despite this,
the structure of the tight junctions associated with these
unusual vessels appeared to be normal (Figure 5(f)).
4.Discussion
Increasing evidence, both clinical and experimental, indi-
cates that an early inﬂammatory insult can aﬀect brain
developmentandbehaviourlaterinlife.Theaimofthisstudy
was to determine whether there is a correlation between
changes in the permeability properties of the blood-brain
barrier induced by a period of neonatal inﬂammation and
later behaviour using the rat as an experimental model.
4.1. Blood-Brain Barrier Permeability and Behaviour. In the
present model of early life inﬂammation some alterations in
blood-brain barrier function and white matter damage have
previously been reported. These include short-term changes
in blood-brainbarrier permeability to proteininyoung pups
and long-term changes to small molecular weight molecules
in adult animals exposed to prolonged inﬂammation during
development [11]. The present study determined that this
long-term permeability change develops sometime after 36 Cardiovascular Psychiatry and Neurology
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Figure 3: Adult animalstreated with either salineor LPSduring the postnatal period were tested fortheir ability to learn and remember and
their general locomotor activity in the Morris Water Maze. No diﬀerence was observed between saline- and LPS-treated animals for any of
the measured parameters. Data are mean ± SEM, n = 8 for each group.
weeks of age, as animals tested at P20 showed no signiﬁcant
change in the permeability of the blood-brain barrier to
sucrose (Table 1). Interestingly, changes in blood vessel tight
junction distribution preceded long-term alterations in both
blood-brain barrier permeability and behaviour.
It has previously been hypothesised that this alteration
in function of the blood-brain barrier in the adult may
contribute to inﬂammation-induced behavioural changes
such as altered prepulse inhibition (PPI). The results from
the current study suggest that changes in PPI occur prior to
the long-term change in barrier function to small molecules,
however they may relate to damage resulting from the
transient increase in protein permeability and white matter
volume reduction that occurs up to P9 [11].
One of the major behavioural modiﬁcations observed in
the present study was a change in sensory-motor gaiting,
demonstrated by PPI test in juvenile rats, but not in
adults following an early inﬂammatory insult (Figure 1).
Changes in PPI have been reported in several studies that
examined eﬀects of systemic inﬂammation during fetal
or early postnatal stages of brain development, however,
some results have been conﬂicting. Fortier and colleagues
[17] found that LPS administered to pregnant mice during
mid to late gestation resulted in reduced PPI in oﬀspring
when adult, whereas polyI:C, which is used to mimic viral
infections, did not. In contrast, higher doses of polyI:C at
comparable ages of gestation have been found to result in
altered PPI in a separate study [24]. Similarly, Fortier et
al. [17] suggested that inﬂammation at very early stages of
gestation (GD10-11) in the mouse did not cause changes in
the PPI response of theadult oﬀspring, while an earlier study
by Shi et al. [18] indicated that inﬂammation-induced either
by viral infection or injection of the polyI:C viral mimic at
GD9.5 did in fact result in a reduced PPI response in adult
oﬀspring. These discrepancies could be due to the diﬀerent
doses of polyI:C used, particularly as inﬂammation has been
associated with increasedserumcortisolconcentrationinthe
perinatal period [25], which in turn has been found to alter
PPI in a dose-speciﬁc manner [26]. This suggests that these
two systems may interact to produce widely diﬀerent results
depending on the magnitude of the initial insult. Therefore,
while changes in PPI are now frequently seen in models of
early life inﬂammatory challenge, the long-term behavioural
outcome is dependent on many factors, including dose of
inﬂammatory agentand gestational age at time of insult. The
present study supports the recent ﬁnding of Ibi et al. [27]
that neonatal inﬂammation, in comparison to inﬂammation
during gestation, also results in long-term alteration in the
PPI response. It also supports the hypothesis of Wolﬀ and
Bilkey [24] that PPI deﬁcits are distinguishable in juvenile
animals.
Behavioural changes seen at P20 for PPI may continue
into adulthood although in this study the diﬀerence between
the two treatment groups was no longer statistically sig-
niﬁcant (Figure 1). LPS challenged animals did however
show a signiﬁcant behavioural change in the Light/Dark test
compared tosaline-treated animals when adult(Figure 2).In
contrast, in animals tested at P20 there was no signiﬁcant
diﬀerence for this test between control and LPS-injected
animals suggesting that the eﬀect seen in adult animals may
take a longer period to develop and is not manifested until
la t eri nli f e.H o w ev er ,i tm a ybeth a tth i si sn ota na ppr opri a t e
t e s tf o rs u c hj u v e n i l ea n i m a l s ,a sm a n yo ft h e m( b o t hs a l i n e -
and LPS-injected) did not enter the light area of the arena at
all during the testing period.
The results of the Light/Dark test obtained for adult
animals were diﬀerent from what might have been expected
from clinical disease associations [28, 29] and some previous
studies. Fetal exposure to inﬂammation (via the dam) in the
C57 mouse produced long-term anxiety-like behaviour onCardiovascular Psychiatry and Neurology 7
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Figure 4: Claudin-5 immunoreactivity was detected on the endothelial cells of brain microvessels. In P9 (a) and adult (c) control brains,
claudin-5 (brown reaction product) appears to be continuous along the length of the microvessels and to form a distinct pattern consistent
with its location at cell-to-cell junctions (higher magniﬁcation in insert in (a)). In P9 (b) and adult (d) animals treated with LPS during
the ﬁrst 8 days of life a proportion of vessels in the brain (see also (e)) showed an altered distribution of claudin-5, with a fainter
immunoreactivity and more diﬀuse staining pattern apparently in the cytoplasm (see insert for cellular distribution pattern in insert in
(b)). Scale bar = 50μm. Inserts show magniﬁcationof regions indicated by box in (a) and (b). (e) illustrates a relative proportion of cerebral
bloodvesselsdisplayingclaudin-5immunoreactivitythatwasobservedas“junctional”orcytoplasmic(seeMethods).This showedthatthere
is a shift towards cytoplasmic staining of claudin-5 in LPS-treated animals at all ages. n = 3 for each group.
the elevated plus maze [30]. However, a study of inﬂamma-
tion in the postnatal rat (P7-28) did not show any increased
anxiety-like behaviour on the same apparatus [31, 32].
The reduced light avoidance exhibited by the LPS-treated
animals in the present study (Figure 2) does not appear to
be due to reduced sensory input. Animals receiving LPS-
injections during infancy responded normally to visual and
auditory stimuli in the Morris Water Maze and PPI. It
therefore seems that much of the apparent conﬂict in results
so far reported in the literature may reﬂect diﬀerences in
timing of inﬂammation during development, the degree of
inﬂammatory insult, the method of inducing it and perhaps
the species.
LPS-treated animals showed no diﬀerence in their
behaviour compared to saline-injected control animals for
either the open ﬁeld or the Morris Water Maze, indicating
that not all aspects of behaviour are aﬀected as a result of
inﬂammatory insult during early postnatal development.
4.2. Tight Junctions. We examined tight junctions both mor-
phologically under the electron microscope and molecularly
using claudin-5 immunoreactivity. Tight junctions located8 Cardiovascular Psychiatry and Neurology
(a) (b)
(c) (d)
(e) (f)
Figure 5: Electronmicrographs of blood vessels in the external capsule of adult control and LPS-treated rats. Most blood vessels appear
identical in control (a) and LPS-treated animals (b), arrows indicate tight junctions. At higher magniﬁcation the tight junctions are visible
and these look normal in LPS-treated animals (d) compared to control animals (c) with several fusions points (arrowheads) along the
intercellular cleft. A small proportion of cerebral capillaries in LPS-treated animals appeared abnormal with convoluted lumen and poorly
structured perivascular space (e). In these vessels the tight junction (arrow in (e)) still appeared normal and at higher magniﬁcation the
characteristic fusionpoints were visible within the tight junction (arrowheads in (f)).Scale bars: 3μm in (a),(b), (e); 200nm in (c), (d), (f).Cardiovascular Psychiatry and Neurology 9
between endothelial cells of cerebral blood vessels are the
structural basis for the blood-brain barriers that normally
severely restrict paracellular permeability from blood into
brain [33]. The present study of blood vessel ultrastructure
in the white matter of adult animals exposed to LPS early in
development showed no apparent alteration in the structure
of tight junctions with several “kissing points” visible as an
indicator of closely apposed membranes.
However, while examining these junctions we found
a small number of the blood vessels that did appear to
havegrossultrastructuralabnormalities(Figure 5).Thegross
ultrastructural changes observed in these vessels are not
dissimilar to those observed in animal models of pericyte
deﬁciency [34] where increased permeability of the blood-
brain barrier was observed. Although the proportion of
these abnormal vessels was low this does not rule out
their potential to inﬂuence blood-brain barrier permeability.
Due to the normally extremely low permeability of cerebral
blood vessels, a few vessels with altered permeability could
signiﬁcantlycontributetotheoverallpropertiesoftheblood-
brain barrier. Although the tight junctions in all vessels
appeared to be normal (including those in the abnormal
vessels, Figure 5), the functionality of these tight junctions
can only be conﬁrmed using electron denser tracers [35].
Sucrose permeability was increased throughout the cortex
in these animals, indicating that other low molecular weight
molecules, such as some drugs or heavy metals, may have
prolonged access to the brain, potentially contributing to
long-term damage of the brain.
The tight junctions are composed of a number of
proteins that are thought to have diﬀerent roles in relation
to paracellular permeability. Disruption of these proteins
has been associated with alterations in blood-brain barrier
permeability [36–38] and the expression of, for example,
claudin-5 can be regulated through protein kinase C by the
actions of a number of cytokines [39]. Molecular alterations
of the tight junction proteins may lead to increased perme-
ability even without ultrastructurally altering the junctions.
In a claudin-5 knockout mouse no overt morphological
abnormalities in the blood vessels were found despite a
size selective increase in blood-brain barrier permeability
[22]; however, as this study did not include EM immuno-
cytochemistry it is not clear what was the cellular route
(paracellular or transcellular) responsible for the observed
increase in barrier permeability to small molecules that was
observed. Although there is a link between altered claudin-
5 distribution and an increase in sucrose permeability in
adultsinthepresentstudy(Table 1),theresultsfromyounger
animals show that LPS treatment can also cause an altered
distribution of claudin-5 protein immunoreactivity that is
not associated with changes in sucrose permeability. In
order to understand these diﬀerences we need a better
understanding of the molecular functions of tight junction
proteins as well as the changes of these proteins that may
occur in response to LPS treatment.
In conclusion, the present results demonstrate that a
period of prolonged systemic inﬂammation in the neonatal
rat can cause a multitude of modiﬁcations that manifest
in later life, ranging from alterations in behaviour, changes
in blood-brain barrier permeability and in structure of
some cerebral blood vessels. The results also show that
these changes develop at diﬀerent times after the initiating
inﬂammatory insult and are not always temporally corre-
lated. The results from the present study are suggestive of
a two-phase progression model: a ﬁrst wave of damage
(i.e., acute blood-brain barrier disruption and white matter
damage [11]) that causes early changes in blood vessel
morphology/composition and early behavioural alterations
and a second phase of damage, induced by the adult-onset
increase in blood-brain barrier permeability, that produces
the later behavioural changes.
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